BLSH Bullish Insider Trading

CEO Farley exercises 160K shares in April, then divests nearly entire position with four sales totaling $3.5M in May.

CEO Farley Thomas W exercised stock options for 160,000 shares across two tranches in April, then liquidated nearly his entire position on a single day in May through four sequential sales at prices ranging from approximately $42 to $45 per share. This represents a striking reversal from option exercise to rapid divestiture—he added shares through compensation, then immediately sold off 80,000 of them, leaving a net gain of 80,000 shares but no meaningful open-market holdings retention. His prior three sales at this company all preceded stock gains, meaning he has been poorly timed on every exit attempt; this latest four-part sale arrives as the stock trades well below its 52-week high after a recent rally. As CEO, Farley holds material knowledge of the business, yet his decision to exercise options and sell within weeks—rather than hold into strength—stands out as distinct from typical executive accumulation patterns. The scale of the liquidation and the poor historical timing of his sales suggest caution may be warranted regardless of the company's fundamental standing.

CEO Farley sells 80,000 BLSH shares in 3 transactions for $2.9M at avg $36.41; retains 4.97M shares.

CEO Thomas W Farley sold 80,000 shares across 3 separate transactions on 2026-04-10, generating $2,912,819.06 at a blended average price of $36.41, while retaining 4,973,528 shares post-transaction. The current price of $38.96 is 47.8% below the 52-week high of $74.63, indicating a substantial decline from recent highs. While the sale represents only a 1.6% reduction in his pre-transaction holdings, the timing coincides with the stock trading well below its 52-week peak, though it has gained 6.4% over the past 30 days.